News

Home

News

A new scientific publication: "Pharmacokinetic and Bioequivalence Study of the Two-component Medication Product "Ezetimibe + rosuvastatin" co-authored by Dmitry Grebenkin, Anastasia Ryabova,

A new scientific publication: "Pharmacokinetic and Bioequivalence Study of the Two-component Medication Product "Ezetimibe + rosuvastatin" co-authored by Dmitry Grebenkin, Anastasia Ryabova,

2023

`Subscribe

We invite you to read the new scientific article "Pharmacokinetic and Bioequivalence Study of the Two-component Medication Product "Ezetimibe + rosuvastatin" (JSC "Sanofi-aventis group", Russia): Resuts and Experience with the Use of Enzymatic Hydrolysis in the Analysis of Samples" co-authored by employees of Analytical Center Exacte Labs - Dmitry Grebenkin, Anastasia Ryabova, Adilya Kuramshina, Ivan Kislyakov and Evgenia Zhukova.

The article was published in the scientific and peer-reviewed journal medications development & registration.

Within the framework of the comparative estimation of the quality of medication preparations presented on the Russian market the study of the test of comparative dissolution kinetics (TDCS) and the index of homogeneity of tablet doses (using the division according to the factory risks applied to tablets) for seven trade names of medication preparations with the INN "captopril" of different manufacturers was conducted.

The full text of the publication can be found here.

Other news

Presentation by Dmitry Grebenkin at the conference "Dialogues on Clinical Trials" Exacte Labs - participant of the conference "Cosmetics Industry: Looking into the Future" An employee of Exacte Labs took part in the roundtable discussion Exacte Labs employees at the conference "Topical issues of prevention, diagnosis and treatment of tuberculosis in children and adolescents"